Filing Details
- Accession Number:
- 0000950170-25-042074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-19 16:38:43
- Reporting Period:
- 2025-03-17
- Filing Date:
- 2025-03-19
- Accepted Time:
- 2025-03-19 16:38:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Achieve Life Sciences Inc. | ACHV | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491847 | K Mark Oki | 22722 29Th Dr Se Suite 100 Bothell WA 98021 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-17 | 10,000 | $2.89 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.9387 per share, inclusive. The Rreporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
